Laboratorios Farmaceuticos Rovi S.A. Logo

Laboratorios Farmaceuticos Rovi S.A.

ROVI | MC

Overview

Corporate Details

ISIN(s):
ES0157261019
LEI:
95980020140005936480
Country:
Spain
Address:
JULIAN CAMARILLO 35, 28037 Madrid
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Laboratorios Farmaceuticos Rovi S.A. is a specialized, fully integrated pharmaceutical company founded in 1946. Its core activities encompass the research, development, manufacturing, and marketing of pharmaceutical products, primarily for prescription and hospital use. The company produces a range of dosage forms, including prefilled syringes, vials, tablets, and sachets. In addition to developing its own products, ROVI provides contract manufacturing services to third parties, offering comprehensive solutions that include production, testing, packaging, and storage. The company also engages in in-licensing to expand its product portfolio.

Social Media

Stop Scraping. Start Analyzing.

You're viewing a fraction of the data available for Laboratorios Farmaceuticos Rovi S.A.. Get complete, real-time, and AI-ready data via the API the pros use.

Get Instant API & Bulk Data Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2025-06-18 00:00
Post-Annual General Meeting Information
La Sociedad informa sobre los acuerdos adoptados por su Junta General Ordinaria…
Spanish 152.8 KB
2025-05-08 07:56
Pre-Annual General Meeting Information
La Sociedad informa sobre el acuerdo de convocatoria de su Junta General Ordina…
Spanish 488.2 KB
2025-05-08 07:54
Regulatory News Service
ROVI informa sobre la concesión de una subvención en su favor para el desarroll…
Spanish 171.1 KB
2025-05-08 07:39
Investor Presentation
La Compañía hace pública la presentación relativa a los resultados financieros …
Spanish 957.7 KB
2025-05-08 07:35
Earnings Release
La Compañía hace público el comunicado de prensa relativo a los resultados fina…
Spanish 631.0 KB
2025-05-08 00:00
Pre-Annual General Meeting Information
La Sociedad informa sobre el acuerdo de convocatoria de su Junta General Ordina…
Spanish 488.2 KB
2025-04-04 10:27
Transaction in Own Shares
Operaciones sobre acciones propias efectuadas en el primer trimestre de 2025 en…
Portuguese 219.9 KB
2025-03-25 10:03
Investor Presentation
La Sociedad hace pública de nuevo la presentación en español relativa a la actu…
Spanish 2.3 MB
2025-03-25 08:00
Investor Presentation
La Sociedad hace pública la presentación relativa a la actualización de su estr…
Spanish 2.3 MB
2025-02-25 07:54
Report Publication Announcement
La Sociedad informa sobre los acuerdos adoptados por su Consejo de Administraci…
Spanish 85.6 KB
2025-02-25 07:49
Investor Presentation
La Sociedad hace pública la presentación de los resultados financieros del ejer…
Spanish 1.4 MB
2025-02-25 07:47
Earnings Release
La Sociedad hace público el comunicado de prensa relativo a los resultados fina…
Spanish 672.9 KB
2025-02-25 07:15
Remuneration Information
La Sociedad remite el Informe Anual sobre remuneraciones de los consejeros del …
Spanish 236.7 KB
2025-02-25 07:10
Governance Information
La sociedad remite el Informe Anual de Gobierno Corporativo del ejercicio 2024
Spanish 3.5 MB
2025-02-25 00:00
Annual / Quarterly Financial Statement
English 615.4 KB

Automate Your Workflow. Get a real-time feed of all Laboratorios Farmaceuticos Rovi S.A. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Laboratorios Farmaceuticos Rovi S.A. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
4BASEBIO PLC Logo
Manufactures GMP-compliant synthetic DNA for advanced therapies, vaccines, and cell/gene therapies.
United Kingdom 4BB
ABINGDON HEALTH PLC Logo
A CDMO for lateral flow rapid tests, providing end-to-end services and its own branded products.
United Kingdom ABDX
ABIONYX Pharma Logo
Biotech developing lipid-based therapies for rare renal and ophthalmological diseases.
France ABNX
AB Science Logo
Develops protein kinase inhibitors for oncology, neuro, and inflammatory diseases.
France AB
AcuCort AB Logo
Develops a rapid oral film for acute allergies, croup, and chemo-induced nausea.
Sweden ACUC
Advicenne Logo
Develops and commercializes therapies for rare renal diseases for patients of all ages.
France ALDVI
AegirBio AB Logo
Makes saliva-based diagnostics accessible for at-home & pro health & drug monitoring.
Sweden AEGIR
Aelis Farma Logo
Developing novel CB1 receptor inhibitors for treating brain and CNS disorders.
France AELIS
AGRONOMICS LIMITED Logo Isle of Man ANIC
ALK-Abelló Logo
Develops allergy immunotherapy (AIT) and emergency treatments for severe allergies.
Denmark ALK